Daiichi Sankyo invests: A pharmaceutical company that remains loyal to Germany

—·5h

Most recently, the drug manufacturers Eli Lilly and Boehringer Ingelheim spectacularly scaled back their investment plans in Germany. A competitor from Japan does it differently.

Channelssemiconductors, stocksCountriesgermany, europe, usa, uk, japanCategoriespharma

Open original source ↗

Published

6/27/2026, 10:18:25 AM

Fetched

6/27/2026, 12:07:17 PM

Confidence

60 / 100

Relevance

40 / 100

Trust

—

Language